Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Comment by Sarb99on Feb 12, 2021 2:36am
124 Views
Post# 32549466

RE:RE:RE:Yes I agree, if you have a Question ask the management

RE:RE:RE:Yes I agree, if you have a Question ask the management
Can you please explain, how is this weak response? All they said in the message was more information to follow. I don't think, they are going to explain everything to me in an email. What I got from the message was, they will issue follow-up news Friday or Monday explaining. If they don't then I can send them an email again with my follow up questions. 
 
I know it is a lot of money, but I am not going to lash out at them without hearing them first. We need to see follow-up news to see if we get more information and it explains. Yes, we as shareholders can ask them the questions, if not satisfied. I am the kind of guy, I will sell and move on. In my opinion, Medivolve is much more than 20 million shares. If you think otherwise then you need to decide, what you want to do with your holding. 
 
You say "As far as Shelburn goes, it's a bit disingenuous to write him off" ok can you tell me what other option you, I or the company have? Yes, Medivolve promised more collection sites than currently in operation. Honestly, I am still ok, if all 126 collection sites are up and running in the next 3-4 weeks generating $30-$35 million per month. 
 
You can see this as you like a glass half empty or half full. 

CerealKiller wrote: Whoops. Posting problem. Again: I don't know, man. That's a very weak response you got from management and 20 million shares is currently worth roughly $8 million? That's a heck of a lot of money and a serious investment for something that nobody can find anything about. Aa far as Shelburn goes, it's a bit disingenuous to write him off as just an employee and how anyone below him can easily take over. Besides, if he's so easily replaceable and already not meeting goals, that's another huge problem unto itself. Ugh.


<< Previous
Bullboard Posts
Next >>